The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
This year’s ESGCT has invited speakers across plenary, parallel and keynote sessions will represent the leading individuals and labs active in the field today. The ESGCT Annual Congresses has become known for their cutting-edge science, up-to-date programming, student engagement activities, and their focus on enabling in-depth networking and collaborations across exhibition, fully catered opening and closing events, coffee and lunch breaks, poster sessions and the famed Molecular Mingle. In Edinburgh, this will take place at the National Museum of Scotland where the galleries will be opened for exploring and will showcase the best of local cuisine and entertainment.